← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 9, 2020Last known activity
Mar 20, 2025
Timeline
2010s
- Jun 1, 2012
reMYND— Founded
Drugs by trial phase (2 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT07016464Lead sponsorPhase 1Mar 20, 2025
- NCT05478031Lead sponsorPhase 2Jun 7, 2022
- NCT04672135Overall official - principal investigatorPhase 1Nov 9, 2020
- NCT04672135Lead sponsorPhase 1Nov 9, 2020
Details
- Founded
- Leuven, BE Jun 1, 2012
- Last known activity
- Mar 20, 2025